| Kilitch Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524500 |
NSE Symbol : KILITCH |
P/E(TTM) : 27.80 |
|
ISIN Demat : INE729D01010 |
Div & Yield% : - |
EPS(TTM) : 10.84 |
|
Book Value(₹) : 138.61 |
Market Cap(₹Cr) : 484.64 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 45.35 | 33.42 | 39.14 | 29.77 | 31.57 | 31.12 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 45.35 | 33.42 | 39.14 | 29.77 | 31.57 | 31.12 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.81 | 3.21 | 0.90 | 3.40 | 0.92 | 0.98 |
| Total Income | 51.16 | 36.63 | 40.03 | 33.16 | 32.49 | 32.10 |
| Total Expenditure | 39.75 | 30.20 | 33.92 | 25.75 | 25.73 | 25.89 |
| PBIDT | 11.40 | 6.43 | 6.11 | 7.41 | 6.76 | 6.22 |
| Interest | 0.42 | 0.49 | 0.44 | 0.53 | 0.55 | 0.38 |
| PBDT | 10.98 | 5.94 | 5.67 | 6.88 | 6.21 | 5.84 |
| Depreciation | 0.40 | 0.35 | 0.41 | 0.30 | 0.28 | 0.26 |
| Tax | 2.16 | 1.27 | 1.32 | 1.30 | 1.76 | 1.99 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.43 | 0.27 | 0.30 | -0.22 | -0.07 | -0.59 |
| Reported Profit After Tax | 8.85 | 4.05 | 3.64 | 5.50 | 4.24 | 4.19 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.85 | 4.05 | 3.64 | 5.50 | 4.24 | 4.19 |
| EPS (Unit Curr.) | 5.50 | 2.52 | 2.26 | 3.48 | 2.60 | 2.69 |
| EPS (Adj) (Unit Curr.) | 5.50 | 2.52 | 2.26 | 3.48 | 2.60 | 2.69 |
| Calculated EPS (Unit Curr.) | 5.50 | 2.52 | 2.26 | 3.42 | 2.64 | 2.69 |
| Calculated EPS (Adj) (Unit Curr.) | 5.50 | 2.52 | 2.26 | 3.42 | 2.64 | 2.69 |
| Calculated EPS (Ann.) (Unit Curr.) | 22.00 | 10.08 | 9.06 | 13.68 | 10.55 | 10.75 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 22.00 | 10.08 | 9.06 | 13.68 | 10.55 | 10.75 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.08 | 16.08 | 16.08 | 16.08 | 16.08 | 15.58 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 25.14 | 19.24 | 15.61 | 24.89 | 21.41 | 19.99 |
| PBDTM(%) | 24.21 | 17.77 | 14.49 | 23.11 | 19.67 | 18.77 |
| PATM(%) | 19.51 | 12.12 | 9.30 | 18.47 | 13.43 | 13.46 |